Clinademi Research Private Limited

05/04/2025

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-expanded-use-amgens-rare-disease-drug-2025-04-03/

The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares in patients with a rare immune system-related condition, the regulator said on Thursday.

07/02/2025

https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisks-new-cagrisema-study-focus-dose-escalation-trial-length-2025-02-05/

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed investors and wiped $125 billion from its market value.

28/11/2024

https://fortune.com/2024/11/26/novo-nordisk-foundation-ceo-nokia-risk-denmark-economy/

Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen said only 9 million people are using GLP-1s compared with 1 billion people living with obesity.

24/09/2024

https://www.moneycontrol.com/news/business/markets/astrazeneca-pharma-shares-in-focus-on-cdsco-permission-12828086.html

AstraZeneca Pharma India Share Price Today | The company has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion (Imfinzi).

24/09/2024

https://fortune.com/europe/2024/09/23/novo-nordisk-nokia-risk-mette-frederiksen-denmark/

But Danish prime minister Mette Frederiksen isn't worried about a 'Nokia risk' from pharma giant.

10/06/2024

24/07/2023

https://medicaldialogues.in/amp/news/industry/pharma/drug-alert-48-drug-samples-fail-to-clear-cdsco-test-1-declared-spurious-114770

New Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), flagged 48 medicine batches for failing to qualify for a random...

04/05/2023

https://m.timesofindia.com/city/delhi/delhi-hc-orders-meet-on-clinical-trials-for-therapies-on-rare-diseases/articleshow/98553571.cms

Delhi high court has directed National Consortium for Rare Diseases to hold a meeting on clinical trials for developing indigenous therapies for D***e

04/05/2023

https://m.timesofindia.com/business/india-business/us-health-regulator-puts-on-hold-sun-pharma-trials-on-dermatological-drug/articleshow/99933458.cms

India Business News: NEW DELHI: The US health regulator has directed Sun Pharma to stop trials of a dermatological drug with a 12 mg dose regimen as its usage could lead t.

04/05/2023

https://www.thehindu.com/sci-tech/health/cdsco-suspends-manufacturing-of-eye-drops-linked-to-adverse-events-in-us/article66471515.ece

NEW DELHI

04/05/2023

https://studycafe.in/cdsco-recruitment-2023-monthly-salary-up-to-45000-check-posts-eligibility-and-how-to-apply-217683.html

CDSCO invites applications from eligible candidates for the post of TDA(Admn./Fin.) in CDSCO (Headquarters). There are 3 vacancies.